198 related articles for article (PubMed ID: 34776964)
21. Average spectral power changes at the hippocampal electroencephalogram in schizophrenia model induced by ketamine.
Sampaio LRL; Borges LTN; Silva JMF; de Andrade FRO; Barbosa TM; Oliveira TQ; Macedo D; Lima RF; Dantas LP; Patrocinio MCA; do Vale OC; Vasconcelos SMM
Fundam Clin Pharmacol; 2018 Feb; 32(1):60-68. PubMed ID: 28853229
[TBL] [Abstract][Full Text] [Related]
22. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
23. Altered adult locomotor activity in rats from phencyclidine treatment on postnatal days 7, 9 and 11, but not repeated ketamine treatment on postnatal day 7.
Boctor SY; Ferguson SA
Neurotoxicology; 2010 Jan; 31(1):42-54. PubMed ID: 19853622
[TBL] [Abstract][Full Text] [Related]
24. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
[TBL] [Abstract][Full Text] [Related]
25. Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats.
Sampaio LRL; Borges LTN; Barbosa TM; Matos NCB; Lima RF; Oliveira MN; Gularte VN; Patrocínio MCA; Macêdo D; Vale OCD; Vasconcelos SMM
J Psychiatr Res; 2017 Mar; 86():73-82. PubMed ID: 27951451
[TBL] [Abstract][Full Text] [Related]
26. Anxiogenic-like effects of chronic cannabidiol administration in rats.
ElBatsh MM; Assareh N; Marsden CA; Kendall DA
Psychopharmacology (Berl); 2012 May; 221(2):239-47. PubMed ID: 22083592
[TBL] [Abstract][Full Text] [Related]
27. Analgesic and Antidepressant Effects of the Clinical Glutamate Modulators Acetyl-L-Carnitine and Ketamine.
Freo U; Brugnatelli V; Turco F; Zanette G
Front Neurosci; 2021; 15():584649. PubMed ID: 34045938
[TBL] [Abstract][Full Text] [Related]
28. Gallic acid prevents ketamine-induced oxidative damages in brain regions and liver of rats.
Schimites PI; Segat HJ; Teixeira LG; Martins LR; Mangini LT; Baccin PS; Rosa HZ; Milanesi LH; Burger ME; Soares AV
Neurosci Lett; 2020 Jan; 714():134560. PubMed ID: 31622649
[TBL] [Abstract][Full Text] [Related]
29. Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study.
Korlatowicz A; Kuśmider M; Szlachta M; Pabian P; Solich J; Dziedzicka-Wasylewska M; Faron-Górecka A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830086
[TBL] [Abstract][Full Text] [Related]
30. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
[TBL] [Abstract][Full Text] [Related]
31. Ketamine-induced hypnosis and neuroplasticity in mice is associated with disrupted p-MEK/p-ERK sequential activation and sustained upregulation of survival p-FADD in brain cortex: Involvement of GABA
Salort G; Álvaro-Bartolomé M; García-Sevilla JA
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():121-131. PubMed ID: 30003929
[TBL] [Abstract][Full Text] [Related]
32. Acute ketamine-induced neuroplasticity: ribosomal protein S6 phosphorylation expression in drug addiction-related rat brain areas.
Tedesco V; Ravagnani C; Bertoglio D; Chiamulera C
Neuroreport; 2013 May; 24(7):388-93. PubMed ID: 23568219
[TBL] [Abstract][Full Text] [Related]
33. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS
Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of reactive oxygen species production accompanying alternatively activated microglia by risperidone in a mouse ketamine model of schizophrenia.
Fujikawa R; Yamada J; Maeda S; Iinuma KM; Moriyama G; Jinno S
J Neurochem; 2024 May; ():. PubMed ID: 38770640
[TBL] [Abstract][Full Text] [Related]
35. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
36. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
Becker A; Grecksch G; Zernig G; Ladstaetter E; Hiemke C; Schmitt U
Psychopharmacology (Berl); 2009 Mar; 202(4):579-87. PubMed ID: 18810393
[TBL] [Abstract][Full Text] [Related]
37. Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia.
Jimenez Naranjo C; Osborne AL; Weston-Green K
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109640. PubMed ID: 31108177
[TBL] [Abstract][Full Text] [Related]
38. Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.
Peres FF; Levin R; Suiama MA; Diana MC; Gouvêa DA; Almeida V; Santos CM; Lungato L; Zuardi AW; Hallak JE; Crippa JA; Vânia D; Silva RH; Abílio VC
Front Pharmacol; 2016; 7():343. PubMed ID: 27733830
[TBL] [Abstract][Full Text] [Related]
39. Effects of Electroacupuncture on Expression of D1 Receptor (D1R), Phosphorylation of Extracellular-Regulated Protein Kinase 1/2 (p-ERK1/2), and c-Fos in the Insular Cortex of Ketamine-Addicted Rats.
Wu F; Ding J; Li HB; Miao HC; Bao R; Yang S
Med Sci Monit Basic Res; 2019 Jan; 25():26-32. PubMed ID: 30700692
[TBL] [Abstract][Full Text] [Related]
40. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
Becker A; Grecksch G
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
